U.S., March 18 -- ClinicalTrials.gov registry received information related to the study (NCT06878612) titled 'a Polyphenol Whole Tumor Cell Vaccine in Patients With Advanced Malignant Solid Tumors' on Feb. 26.
Brief Summary: This project intends to carry out phase I clinical studies on the basis of the previous work, initially exploring the possible effective dose, evaluating its safety and tolerability, with a view to achieving long-term control of the disease, which is expected to provide more options for the treatment of patients with advanced malignant solid tumors. The development of this project will provide new ideas, strategies and theoretical basis for the research and development of whole tumor cell vaccines; at the same time, it...